| UniProt ID | SETBP_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y6X0 | |
| Protein Name | SET-binding protein | |
| Gene Name | SETBP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1596 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | ||
| Protein Sequence | MESRETLSSSRQRGGESDFLPVSSAKPPAAPGCAGEPLLSTPGPGKGIPVGGERMEPEEEDELGSGRDVDSNSNADSEKWVAGDGLEEQEFSIKEANFTEGSLKLKIQTTKRAKKPPKNLENYICPPEIKITIKQSGDQKVSRAGKNSKATKEEERSHSKKKLLTASDLAASDLKGFQPQAYERPQKHSTLHYDTGLPQDFTGDTLKPKHQQKSSSQNHMDWSTNSDSGPVTQNCFISPESGRETASTSKIPALEPVASFAKAQGKKGSAGNTWSQLSNNNKDLLLGGVAPSPSSHSSPAPPSSSAECNGLQPLVDQDGGGTKEPPEPPTVGSKKKSSKKDVISQTIPNPDLDWVKNAQKAFDNTEGKREGYSADSAQEASPARQNVSSASNPENDSSHVRITIPIKAPSLDPTNHKRKKRQSIKAVVEKIMPEKALASGITMSSEVVNRILSNSEGNKKDPRVPKLSKMIENESPSVGLETGGNAEKVIPGGVSKPRKPPMVMTPPTCTDHSPSRKLPEIQHPKFAAKRRWTCSKPKPSTMLREAVMATSDKLMLEPPSAYPITPSSPLYTNTDSLTVITPVKKKRGRPKKQPLLTVETIHEGTSTSPVSPISREFPGTKKRKRRRNLAKLAQLVPGEDKPMSEMKFHKKVGKLGVLDKKTIKTINKMKTLKRKNILNQILSCSSSVALKAKAPPETSPGAAAIESKLGKQINVSKRGTIYIGKKRGRKPRAELPPPSEEPKTAIKHPRPVSSQPDVPAVPSNFQSLVASSPAAMHPLSTQLGGSNGNLSPASTETNFSELKTMPNLQPISALPTKTQKGIHSGTWKLSPPRLMANSPSHLCEIGSLKEITLSPVSESHSEETIPSDSGIGTDNNSTSDQAEKSSESRRRYSFDFCSLDNPEAIPSDTSTKNRHGHRQKHLIVDNFLAHESLKKPKHKRKRKSLQNRDDLQFLADLEELITKFQVFRISHRSYTFYHENPYPSIFRINFDHYYPVPYIQYDPLLYLRRTSDLKSKKKRGRPAKTNDTMTKVPFLQGFSYPIPSGSYYAPYGMPYTSMPMMNLGYYGQYPAPLYLSHTLGAASPFMRPTVPPPQFHTNSHVKMSGAAKHKAKHGVHLQGPVSMGLGDMQPSLNPPKVGSASLSSGRLHKRKHKHKHKHKEDRILGTHDNLSGLFAGKATGFSSHILSERLSSADKELPLVSEKNKHKEKQKHQHSEAGHKASKNNFEVDTLSTLSLSDAQHWTQAKEKGDLSSEPVDSCTKRYSGSGGDGGSTRSENLDVFSEMNPSNDKWDSDVSGSKRRSYEGFGTYREKDIQAFKMNRKERSSYDSSMSPGMPSPHLKVDQTAVHSKNEGSVPTMMTRKKPAAVDSVTIPPAPVLSLLAASAATSDAVGSSLKKRFKRREIEAIQCEVRKMCNYTKILSTKKNLDHVNKILKAKRLQRQSKTGNNFVKKRRGRPRKQPTQFDEDSRDQMPVLEKCIDLPSKRGQKPSLSPLVLEPAASQDTIMATIEAVIHMAREAPPLPPPPPPPLPPPPPPPLPPPPPLPKTPRGGKRKHKPQAPAQPPQQSPPQQPLPQEEEVKAKRQRKSRGSESEVLP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MESRETLSSS -----CCCHHHHHHH | 47.47 | 24114839 | |
| 6 | Phosphorylation | --MESRETLSSSRQR --CCCHHHHHHHHHC | 30.72 | 24114839 | |
| 6 | O-linked_Glycosylation | --MESRETLSSSRQR --CCCHHHHHHHHHC | 30.72 | 30379171 | |
| 8 | Phosphorylation | MESRETLSSSRQRGG CCCHHHHHHHHHCCC | 33.42 | 24114839 | |
| 9 | Phosphorylation | ESRETLSSSRQRGGE CCHHHHHHHHHCCCC | 32.43 | 24114839 | |
| 10 | Phosphorylation | SRETLSSSRQRGGES CHHHHHHHHHCCCCC | 29.11 | 24043423 | |
| 92 | Phosphorylation | GLEEQEFSIKEANFT CCCCCEEEEEECCCC | 31.81 | 24719451 | |
| 132 | Phosphorylation | CPPEIKITIKQSGDQ CCCCCEEEEEECCCH | 19.67 | 24719451 | |
| 140 | Acetylation | IKQSGDQKVSRAGKN EEECCCHHHHCCCCC | 47.09 | 7364715 | |
| 146 | Acetylation | QKVSRAGKNSKATKE HHHHCCCCCCCCCHH | 58.00 | 7364725 | |
| 172 | Phosphorylation | TASDLAASDLKGFQP HHHHHHHHHCCCCCC | 37.56 | - | |
| 259 | Phosphorylation | PALEPVASFAKAQGK CCHHHHHHHHHHCCC | 26.43 | 28060719 | |
| 273 | Phosphorylation | KKGSAGNTWSQLSNN CCCCCCCHHHHHHHC | 26.10 | - | |
| 381 | Phosphorylation | ADSAQEASPARQNVS CCHHHHCCCCCCCCC | 20.52 | 28348404 | |
| 403 | Phosphorylation | DSSHVRITIPIKAPS CCCCEEEEEEEECCC | 15.33 | 24719451 | |
| 439 | Phosphorylation | MPEKALASGITMSSE CCHHHHHCCCCCCHH | 31.42 | - | |
| 453 | Phosphorylation | EVVNRILSNSEGNKK HHHHHHHHCCCCCCC | 35.62 | 22210691 | |
| 508 | Phosphorylation | PMVMTPPTCTDHSPS CCCCCCCCCCCCCCC | 29.28 | 28348404 | |
| 510 | Phosphorylation | VMTPPTCTDHSPSRK CCCCCCCCCCCCCCC | 38.94 | 28348404 | |
| 513 | Phosphorylation | PPTCTDHSPSRKLPE CCCCCCCCCCCCCCC | 27.64 | 28348404 | |
| 565 | Phosphorylation | PPSAYPITPSSPLYT CCCCCCCCCCCCCCC | 16.77 | 28348404 | |
| 567 | Phosphorylation | SAYPITPSSPLYTNT CCCCCCCCCCCCCCC | 35.62 | 28348404 | |
| 568 | Phosphorylation | AYPITPSSPLYTNTD CCCCCCCCCCCCCCC | 21.81 | 28348404 | |
| 571 | Phosphorylation | ITPSSPLYTNTDSLT CCCCCCCCCCCCCEE | 11.00 | 28348404 | |
| 572 | Phosphorylation | TPSSPLYTNTDSLTV CCCCCCCCCCCCEEE | 39.05 | 28348404 | |
| 574 | Phosphorylation | SSPLYTNTDSLTVIT CCCCCCCCCCEEEEE | 21.11 | 28348404 | |
| 576 | Phosphorylation | PLYTNTDSLTVITPV CCCCCCCCEEEEECC | 24.73 | 28348404 | |
| 581 | Phosphorylation | TDSLTVITPVKKKRG CCCEEEEECCCCCCC | 20.07 | - | |
| 611 | Phosphorylation | GTSTSPVSPISREFP CCCCCCCCCCCCCCC | 21.65 | 27251275 | |
| 614 | Phosphorylation | TSPVSPISREFPGTK CCCCCCCCCCCCCCH | 29.19 | 17081983 | |
| 683 | Phosphorylation | NILNQILSCSSSVAL HHHHHHHHCCCHHHH | 17.37 | 27174698 | |
| 685 | Phosphorylation | LNQILSCSSSVALKA HHHHHHCCCHHHHHC | 23.44 | 27174698 | |
| 686 | Phosphorylation | NQILSCSSSVALKAK HHHHHCCCHHHHHCC | 32.91 | 27174698 | |
| 687 | Phosphorylation | QILSCSSSVALKAKA HHHHCCCHHHHHCCC | 8.63 | 27174698 | |
| 720 | Phosphorylation | INVSKRGTIYIGKKR EEECCCCEEEECCCC | 18.03 | - | |
| 725 | Methylation | RGTIYIGKKRGRKPR CCEEEECCCCCCCCC | 29.73 | - | |
| 817 | Acetylation | PISALPTKTQKGIHS CCCCCCCCCCCCCCC | 47.20 | - | |
| 818 | Phosphorylation | ISALPTKTQKGIHSG CCCCCCCCCCCCCCC | 37.68 | 26552605 | |
| 824 | Phosphorylation | KTQKGIHSGTWKLSP CCCCCCCCCCCCCCC | 35.68 | 26552605 | |
| 826 | Phosphorylation | QKGIHSGTWKLSPPR CCCCCCCCCCCCCCC | 23.57 | 27251275 | |
| 830 | Phosphorylation | HSGTWKLSPPRLMAN CCCCCCCCCCCHHCC | 29.18 | 26552605 | |
| 838 | Phosphorylation | PPRLMANSPSHLCEI CCCHHCCCHHHEEEE | 20.45 | 28348404 | |
| 840 | Phosphorylation | RLMANSPSHLCEIGS CHHCCCHHHEEEECC | 28.98 | 32142685 | |
| 893 | Phosphorylation | SESRRRYSFDFCSLD HHHHHHHEEEEECCC | 19.27 | 28348404 | |
| 898 | Phosphorylation | RYSFDFCSLDNPEAI HHEEEEECCCCCCCC | 38.46 | 22210691 | |
| 910 | Phosphorylation | EAIPSDTSTKNRHGH CCCCCCCCCCCCCCC | 42.23 | 22210691 | |
| 911 | Phosphorylation | AIPSDTSTKNRHGHR CCCCCCCCCCCCCCC | 34.14 | 22210691 | |
| 993 | Phosphorylation | FRINFDHYYPVPYIQ EEEECCCCCCCCCEE | 16.00 | 26552605 | |
| 994 | Phosphorylation | RINFDHYYPVPYIQY EEECCCCCCCCCEEC | 8.37 | 26552605 | |
| 998 | Phosphorylation | DHYYPVPYIQYDPLL CCCCCCCCEECCCHH | 10.82 | 26552605 | |
| 1001 | Phosphorylation | YPVPYIQYDPLLYLR CCCCCEECCCHHHHH | 15.23 | 26552605 | |
| 1006 | Phosphorylation | IQYDPLLYLRRTSDL EECCCHHHHHCHHHC | 13.07 | 26552605 | |
| 1024 | "N6,N6-dimethyllysine" | KKRGRPAKTNDTMTK HHCCCCCCCCCCCCC | 51.01 | - | |
| 1024 | Methylation | KKRGRPAKTNDTMTK HHCCCCCCCCCCCCC | 51.01 | - | |
| 1039 | Phosphorylation | VPFLQGFSYPIPSGS CCCCCCCCCCCCCCC | 36.50 | - | |
| 1040 | Phosphorylation | PFLQGFSYPIPSGSY CCCCCCCCCCCCCCC | 11.70 | - | |
| 1192 | Phosphorylation | ILSERLSSADKELPL HHHHHHHHCCCCCCC | 45.11 | 24719451 | |
| 1201 | Phosphorylation | DKELPLVSEKNKHKE CCCCCCCCCCHHHHH | 51.00 | 24719451 | |
| 1263 | Phosphorylation | VDSCTKRYSGSGGDG CCCCCCCCCCCCCCC | 20.95 | 19690332 | |
| 1264 | Phosphorylation | DSCTKRYSGSGGDGG CCCCCCCCCCCCCCC | 30.43 | 19690332 | |
| 1266 | Phosphorylation | CTKRYSGSGGDGGST CCCCCCCCCCCCCCC | 33.39 | 19690332 | |
| 1272 | Phosphorylation | GSGGDGGSTRSENLD CCCCCCCCCCCCCCC | 26.61 | 19690332 | |
| 1273 | Phosphorylation | SGGDGGSTRSENLDV CCCCCCCCCCCCCCC | 41.30 | - | |
| 1298 | Phosphorylation | WDSDVSGSKRRSYEG CCCCCCCCCCCCCCC | 18.58 | - | |
| 1354 | Phosphorylation | VHSKNEGSVPTMMTR ECCCCCCCCCCCCCC | 20.81 | 22210691 | |
| 1379 | Phosphorylation | IPPAPVLSLLAASAA CCCHHHHHHHHHHHH | 22.90 | 25332170 | |
| 1384 | Phosphorylation | VLSLLAASAATSDAV HHHHHHHHHHCCHHH | 16.90 | 25332170 | |
| 1387 | Phosphorylation | LLAASAATSDAVGSS HHHHHHHCCHHHHHH | 27.19 | 25332170 | |
| 1394 | Phosphorylation | TSDAVGSSLKKRFKR CCHHHHHHHHHHHHH | 37.98 | - | |
| 1417 | Phosphorylation | EVRKMCNYTKILSTK HHHHHHCHHHHHCCC | 12.41 | 28060719 | |
| 1418 | Phosphorylation | VRKMCNYTKILSTKK HHHHHCHHHHHCCCC | 9.53 | 28060719 | |
| 1422 | Phosphorylation | CNYTKILSTKKNLDH HCHHHHHCCCCCHHH | 41.47 | 24719451 | |
| 1432 | Ubiquitination | KNLDHVNKILKAKRL CCHHHHHHHHHHHHH | 48.61 | - | |
| 1445 | Phosphorylation | RLQRQSKTGNNFVKK HHHHHCCCCCCHHHH | 50.84 | - | |
| 1451 | Acetylation | KTGNNFVKKRRGRPR CCCCCHHHHHCCCCC | 36.10 | 30585821 | |
| 1452 | Acetylation | TGNNFVKKRRGRPRK CCCCHHHHHCCCCCC | 41.86 | 30585827 | |
| 1483 | Phosphorylation | EKCIDLPSKRGQKPS HHHHCCCCCCCCCCC | 42.13 | 24719451 | |
| 1484 | Acetylation | KCIDLPSKRGQKPSL HHHCCCCCCCCCCCC | 59.62 | 7823431 | |
| 1587 | Phosphorylation | KAKRQRKSRGSESEV HHHHHHHHCCCCCCC | 44.02 | 27251275 | |
| 1590 | Phosphorylation | RQRKSRGSESEVLP- HHHHHCCCCCCCCC- | 36.52 | 27251275 | |
| 1592 | Phosphorylation | RKSRGSESEVLP--- HHHCCCCCCCCC--- | 34.40 | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SETBP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SETBP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SETBP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SET_HUMAN | SET | physical | 11231286 | |
| A4_HUMAN | APP | physical | 21832049 | |
| PP2AA_HUMAN | PPP2CA | physical | 25306901 | |
| SETBP_HUMAN | SETBP1 | physical | 25416956 | |
| SPNXA_HUMAN | SPANXA1 | physical | 25416956 | |
| LCHN_HUMAN | KIAA1147 | physical | 25416956 | |
| SPNXD_HUMAN | SPANXD | physical | 25416956 | |
| SPNXC_HUMAN | SPANXC | physical | 25416956 | |
| PKHF2_HUMAN | PLEKHF2 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 269150 | Schinzel-Giedion midface retraction syndrome (SGMFS) | |||||
| 23832012). Myeloid malignancies are separated into three main categories | Note=SETBP1 somatic mutations are frequently found in myeloid malignancies. They cause gain of function associated with myeloid leukemic transformation (PubMed | |||||
| 614286 | ||||||
| 616078 | Mental retardation, autosomal dominant 29 (MRD29) | |||||
| 601626 | Leukemia, acute myelogenous (AML) | |||||
| 608232 | Leukemia, chronic myeloid, atypical (ACML) | |||||
| 607785 | Leukemia, juvenile myelomonocytic (JMML) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-687, AND MASSSPECTROMETRY. | |